CL

Christopher Liu Leerink Partners Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
4
Avg Return
Past Year
20%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 100%
Neutral 0%
Negative 0%
Stock Rating Price Target Upside
Downside 		Ratings
1 Year 		Avg Return
1 Year 		Success Rate
1 Year 		Date
Outperform Upgraded
$48
9%
upside
1 +28%
0 %
21 Oct ‘25 2 months ago
Buy Initiated
$20
18%
downside
1 +91%
0 %
26 Sep ‘25 3 months ago
Buy Initiated
$9
445%
upside
1 -19%
0 %
18 Sep ‘25 3 months ago
Buy Initiated
$10
268%
upside
1 -18%
0 %
21 Jul ‘25 5 months ago